CHERRY HILL, N.J., May 27 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), an emerging healthcare consumer products company, today announces Jayhur Enterprises will distribute Infinitink (the world's first permanent tattoo ink designed for easier removal) in Australia and New Zealand.
The distribution agreement grants Jayhur Enterprises (Sydney, Australia) a five-year, exclusive contract to market, promote, market, distribute and sell Infinitink in the high potential markets of Australia and New Zealand.
Based on the age of the population and popularity of tattoos in Australia alone, Nuvilex estimates that if Jayhur Enterprises captures 30% of today's market by the end of the agreement, the annual revenue could be as high as $3.75MM. In addition, if trends hold from the US, 15% of Australia's population over 15 years of age is considering a tattoo, but have reservations due to the permanence of the art form. These 'fence sitters' are excellent candidates for artists offering Infinitink tattoos.
"We are very pleased to begin distribution of Infinitink in Australia and New Zealand," said Martin E. Schmieg, Chairman and CEO of Nuvilex, Inc. "We believe the region offers an excellent opportunity for Infinitink sales, and we look forward to working with Jayden Hurvitz and his team at Jayhur Enterprises."
Jayhur Enterprises joins with MT.Derm, GmbH, Berlin, Germany as Infinitink international distributors. MT.Derm owns Infinitink European distribution rights and since 2006 has been a development partner with Freedom2. Nuvilex is seeking a distributor for Latin and South America.
Infinitink is the result of advanced research by physician scientists at
About Nuvilex, Inc.
Nuvilex, formerly eFoodSafety.com, is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare products that address the health needs of consumers worldwide. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., a diversified skin products technology company serving the fast-growing body art, aesthetic, cosmetic and skin therapy markets. More information is available at: http://www.nuvilex.com or www.freedom2inc.com.
Safe Harbor Statement
Statements contained in this presentation that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and involve a number of risks and uncertainties that could cause the Company's actual results to differ materially from projected results. All parties are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, the planned share exchange with Freedom2 Holdings, Inc., our ability to secure additional financing, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
Investor Relations Contacts: Blair Barnes Senior Vice President and Chief Financial Officer Nuvilex, Inc. Ph: 856-433-6088 Email: firstname.lastname@example.org Stephanie Carrington/Amy Glynn The Ruth Group Ph: 646-536-7017/7023 Email: email@example.com Email: firstname.lastname@example.org Press Contact: Pat Arcand Arcand & Madison Ph: 617-576-7777 Email: email@example.com
|SOURCE Nuvilex, Inc.|
Copyright©2009 PR Newswire.
All rights reserved